Biologic therapy with anti-TNFa in rheumathoid atrhritis
Objective: To evaluate the efficacy, the tolerability, and treatment survival of the association of anti-TNFa (Infliximab, Etanercept, Adalimumab) plus Methotrexate vs Methotrexate as monotherapy in patients with reumathoid arthritis (RA). Methods: Review of published controlled randomized clinical...
Saved in:
Main Author: | G. Ferraccioli (Author) |
---|---|
Format: | Book |
Published: |
PAGEPress Publications,
2011-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Safety of anti-TNFa biological drugs
by: G. Valentini, et al.
Published: (2011) -
Biologic therapy with anti-TNFa in spondyloarthritides and other autoimmune diseases
by: G. Lapadula
Published: (2011) -
Are there differences among anti-TNFa biological drugs?
by: G. Valesini
Published: (2011) -
Approved indications and other possible utilizations of anti-TNFa biologic drugs
by: C. Montecucco, et al.
Published: (2011) -
Side effects of anti-TNFa therapy in juvenile idiopathic arthritis
by: Elisabetta Valcamonica, et al.
Published: (2011)